Kata Bölcskei Selected Research

Kata Bölcskei Research Topics

Disease

24	Hyperalgesia 01/2022 - 05/2003
12	Pain (Aches) 01/2022 - 09/2004
8	Inflammation (Inflammations) 10/2021 - 02/2016
8	Arthritis (Polyarthritis) 02/2021 - 07/2005
4	Migraine Disorders (Migraine) 02/2022 - 01/2016
4	Neuralgia (Stump Neuralgia) 03/2021 - 09/2003
4	Rheumatoid Arthritis 02/2021 - 10/2014
4	Demyelinating Diseases (Demyelinating Disease) 01/2020 - 12/2016
4	Edema (Dropsy) 01/2019 - 10/2014
3	Neuroinflammatory Diseases 02/2022 - 04/2020
2	Hypotension (Low Blood Pressure) 01/2022 - 07/2005
2	Facial Pain (Myofacial Pain) 04/2020 - 01/2016
2	Chronic Pain 10/2017 - 01/2017
1	Headache (Headaches) 10/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2021
1	Movement Disorders (Movement Disorder) 01/2019
1	Mononeuropathies (Mononeuritis Multiplex) 01/2018
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 12/2017
1	Necrosis 12/2017
1	Infections 12/2017
1	Mycoplasma Infections 12/2017
1	Synovitis 02/2016
1	Mood Disorders (Mood Disorder) 02/2016
1	Hypersensitivity (Allergy) 01/2016
1	Alzheimer Disease (Alzheimer's Disease) 04/2015
1	Osteophyte 10/2014
1	Hyperplasia 10/2014
1	Immune System Diseases (Immune Disorders) 10/2014

Drug/Important Bio-Agent (IBA)

6	resiniferatoxinIBA 02/2021 - 05/2003
6	Capsaicin (Zostrix)FDA Link 02/2021 - 07/2005
6	Formaldehyde (Formol)FDA Link 01/2018 - 09/2004
6	TRPV1 receptorIBA 10/2017 - 07/2005
5	AnkyrinsIBA 12/2019 - 01/2018
5	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 02/2016 - 09/2004
4	Analgesics (Analgesic Drugs)IBA 01/2018 - 05/2003
3	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 02/2022 - 01/2009
3	NeuropeptidesIBA 02/2021 - 09/2003
3	Freund's AdjuvantIBA 04/2020 - 07/2005
3	CuprizoneIBA 12/2019 - 12/2016
3	Peroxidase (Myeloperoxidase)IBA 01/2019 - 10/2014
3	Opioid Analgesics (Opioids)IBA 01/2018 - 06/2007
3	Morphine (MS Contin)FDA LinkGeneric 03/2009 - 05/2003
3	Diclofenac (SR 38)FDA LinkGeneric 03/2009 - 05/2003
2	Pharmaceutical PreparationsIBA 01/2022 - 01/2018
2	CytokinesIBA 01/2022 - 10/2021
2	incobotulinumtoxinA FDA Link 01/2019 - 01/2017
2	Lipoxygenase (Lipoxygenase-1)IBA 02/2010 - 07/2005
2	Non-Narcotic Analgesics (Analgesics, Non Narcotic)IBA 03/2009 - 06/2007
2	CarrageenanIBA 01/2009 - 10/2005
2	Streptozocin (Streptozotocin)FDA Link 10/2005 - 09/2004
1	Neuroprotective AgentsIBA 02/2022
1	Type II Vasoactive Intestinal Peptide ReceptorsIBA 02/2022
1	9-phenanthrolIBA 01/2022
1	tofacitinibIBA 01/2022
1	Etanercept (Enbrel)FDA Link 01/2022
1	Janus Kinase InhibitorsIBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	dimethyl trisulfideIBA 03/2021
1	hemokinin-1IBA 04/2020
1	IodidesIBA 01/2020
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2020
1	Sulfides (Thioethers)IBA 01/2019
1	GYY 4137IBA 01/2019
1	Type A Botulinum Toxins (Botox)FDA Link 01/2019
1	Ion Channels (Ion Channel)IBA 01/2019
1	Proteoglycans (Proteoglycan)IBA 12/2018
1	Amine Oxidase (Copper-Containing)IBA 01/2018
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2018
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2018
1	VildagliptinIBA 01/2018
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2018
1	AgglutininsIBA 12/2017
1	Estradiol (Delestrogen)FDA LinkGeneric 10/2017
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2017
1	Substance PIBA 01/2017
1	2,3,4-tri-O-acetylarabinopyranosyl isothiocyanate (AITC)IBA 06/2016
1	Peptide Hydrolases (Proteases)FDA Link 02/2016
1	U 0126 (UO 126)IBA 02/2016
1	Leukocyte Elastase (Neutrophil Elastase)IBA 02/2016
1	Sumatriptan (Imigran)FDA LinkGeneric 01/2016
1	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2016
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2016
1	somatostatin receptor 2IBA 04/2015
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 04/2015
1	Proteins (Proteins, Gene)FDA Link 04/2015
1	AutoantibodiesIBA 03/2015
1	Matrix Metalloproteinases (MMPs)IBA 03/2015
1	gamma-Aminobutyric Acid (GABA)IBA 12/2012
1	L 838,417IBA 12/2012
1	3'- (5- (1- hydroxy- 1- methylethyl)benzoimidazol- 1- yl)biphenyl- 2- carbonitrileIBA 12/2012
1	3- (4- t- butylphenyl)- N- (2,3- dihydrobenzo(b)(1,4)dioxin- 6- yl)acrylamideIBA 09/2010
1	SB 705498IBA 09/2010
1	2,5-dichloro-4-bromophenol (B 2)IBA 02/2010

Therapy/Procedure

6	Ligation 03/2021 - 09/2003
2	Drug Therapy (Chemotherapy) 03/2021 - 01/2017
2	Therapeutics 01/2019 - 10/2014
2	Lasers (Laser) 12/2017 - 01/2016
1	Aftercare (After-Treatment) 01/2022
1	Injections 01/2018